Abbott Expansion Plans Indicate Confidence In Pharma Growth

US pharmaceutical giant Abbott Laboratories is reportedly planning to double production volumes in Mexico to 120mn units by 2010 under a three-year-plan announced in an interview with a senior executive from the Mexican financial newspaper El Financiero in mid-January. The company's expansion plans reflect the continued dynamic growth in the overall Mexican pharmaceutical market that BMI predicts will reach a value of US$16.3bn by the end of the

To read the full article, please choose one of the following options: